July 21, 2021
Gift will fund research into molecular underpinnings of peak human performance
Gift will fund research into molecular underpinnings of peak human performance
LA JOLLA—A Salk Institute team led by Professor 萨钦·潘达, along with teams from five other organizations, have been awarded a total of $220 million by the Joe and Clara Tsai Foundation’s Human Performance Alliance, whose philanthropic investment aims to transform human health on a global scale through the discovery and translation of the biological principles underlying human performance.
“The Institute has long been known for its discoveries into cellular mechanisms that lead to disease, but, like the Alliance, Salk is also very focused on maintaining health,” says Salk President 鲁斯蒂·盖奇. “This generous gift from Clara Wu and Joe Tsai to study performance will greatly help Salk reveal new insights into better performance for athletes and better health for everyone.”

Panda, a world expert in how human biological clocks contribute to health or disease, will lead the Salk team to map the molecules and gene activity of human performance that can help maximize performance, healing and recovery.
“The Human Performance Alliance’s dedication to uncovering the principles of elite athletic performance to help all people live stronger, healthier, more fulfilling lives is truly commendable,” says Panda, who holds the Rita and Richard Atkinson Chair. “It aligns completely with my vision of circadian rhythms in metabolism, repair and rejuvenation, as well as with the Salk Institute’s deep commitment to basic research for the benefit of all humanity.”
Panda’s research centers on circadian rhythms, the 24-hour cycles that govern our internal body clocks. His lab has found that hundreds to thousands of genes in our genome turn on and off in different organs at specific times during the 24-hour day. His body of work suggests that there may be optimal times for activities such as eating, sleeping and working out that, in turn, reduce tissue damage and promote optimal healing to sustain high performance.
As one of four “scientific moonshoots” being led by a team of faculty collaborators from different disciplines and multiple institutions across the country as part of the Human Performance Alliance, the Molecular Athlete moonshot is based at the Salk Institute. The Salk team will work on uncovering the molecular signatures of performance, and will collaborate with teams at UC San Diego, Stanford University, the University of Kansas, the University of Oregon, and Boston Children’s Hospital to translate scientific findings into practice.
Other Salk faculty on the moonshot team include Professor and Howard Hughes Medical Institute Investigator 约瑟夫·埃克尔; Assistant Professor 丹妮尔·恩格尔; and Professors Susan Kaech, Joseph Noel 和 艾伦·萨加特利安.
The Human Performance Alliance involves three large public universities and three private institutions: Stanford University, UC San Diego, the University of Kansas, Boston Children’s Hospital, the University of Oregon and the Salk Institute.
The data generated by the Human Alliance will be freely available globally, to ensure its commitment to collaboration, diversity and inclusivity.
宣传办公室
电话:(858) 453-4100
press@salk.edu
萨尔克研究所是一个独立的非营利性研究机构,由首个安全有效的脊髓灰质炎疫苗的研发者乔纳斯·索尔克于1960年创立。该研究所的使命是推动以合作、敢于冒险为特点的基础性研究,以应对癌症、阿尔茨海默病和农业脆弱性等社会最紧迫的挑战。这项基础科学支撑着所有的转化研究,产生有助于全球新药和创新的见解。.